Literature DB >> 4264636

Interaction of SH 1 -blocked HMM with actin and ATP.

R Silverman, E Eisenberg, W W Kielley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4264636     DOI: 10.1038/newbio240207a0

Source DB:  PubMed          Journal:  Nat New Biol        ISSN: 0090-0028


× No keyword cloud information.
  8 in total

1.  SH-1 modification of rabbit myosin interferes with calcium regulation.

Authors:  M A Titus; G Ashiba; A G Szent-Györgyi
Journal:  J Muscle Res Cell Motil       Date:  1989-02       Impact factor: 2.698

2.  The effect of myosin sulphydryl modification on the mechanics of fibre contraction.

Authors:  M S Crowder; R Cooke
Journal:  J Muscle Res Cell Motil       Date:  1984-04       Impact factor: 2.698

3.  Cooperativity of thiol-modified myosin filaments. ATPase and motility assays of myosin function.

Authors:  D D Root; E Reisler
Journal:  Biophys J       Date:  1992-09       Impact factor: 4.033

4.  Myosin ATP hydrolysis: a mechanism involving a magnesium chelate complex.

Authors:  M Burke; E Reisler; W F Harrington
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

5.  Regulation of binding of subfragment 1 in isolated rigor myofibrils.

Authors:  D R Swartz; M L Greaser; B B Marsh
Journal:  J Cell Biol       Date:  1990-12       Impact factor: 10.539

6.  Qualitative analysis of skeletal myosin as substrate of Ca2+-activated neutral protease: comparison of filamentous and soluble, native, and L2-deficient myosin.

Authors:  S M Pemrick; R C Grebenau
Journal:  J Cell Biol       Date:  1984-12       Impact factor: 10.539

7.  N-ethylmaleimide-modified heavy meromyosin. A probe for actomyosin interactions.

Authors:  R L Meeusen; W Z Cande
Journal:  J Cell Biol       Date:  1979-07       Impact factor: 10.539

8.  N-ethylmaleimide-modified subfragment-1 and heavy meromyosin inhibit reactivated contraction in motile models of retinal cones.

Authors:  K Porrello; W Z Cande; B Burnside
Journal:  J Cell Biol       Date:  1983-02       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.